Kun-Zhe Wu
-
- MicroRNA in disease regulation 5
- Cancer-related molecular mechanisms research 5
-
- Nanoparticle-Based Drug Delivery 2
-
- Colorectal Cancer Surgical Treatments 2
-
- RNA modifications and cancer 5
- RNA Interference and Gene Delivery 2
-
- Gastric Cancer Management and Outcomes 3
- Ferroptosis and cancer prognosis 2
- Co-authors
- Cheng ZhangDong‐Qiu DaiChun‐Dong ZhangMing-Hui MaJun‐Peng PeiJinlan JiangLiang YuBeibei Yu
- Cited by
- Cancer ResearchBiomaterialsOncology
In The Last Decade
Kun-Zhe Wu
19 papers receiving 316 citations
Peers
Comparison fields: 5 of 62
- Cancer Research 118
- Biomaterials 40
- Oncology 70
- Molecular Biology 160
- Pulmonary and Respiratory Medicine 68
Countries citing papers authored by Kun-Zhe Wu
This map shows the geographic impact of Kun-Zhe Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kun-Zhe Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kun-Zhe Wu more than expected).
Fields of papers citing papers by Kun-Zhe Wu
This network shows the impact of papers produced by Kun-Zhe Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kun-Zhe Wu. The network helps show where Kun-Zhe Wu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kun-Zhe Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 10 | |
| 2 | 2023 | 6 | |
| 3 | 2022 | 10 | |
| 4 | 2022 | 22 | |
| 5 | 2022 | 14 | |
| 6 | 2022 | 37 | |
| 7 | 2022 | 6 | |
| 8 | 2021 | 16 | |
| 9 | 2020 | 22 | |
| 10 | 2020 | 12 | |
| 11 | 2020 | 8 | |
| 12 | 2020 | 13 | |
| 13 | 2020 | 25 | |
| 14 | 2020 | 12 | |
| 15 | 2020 | 7 | |
| 16 | 2019 | 16 | |
| 17 | 2019 | 39 | |
| 18 | 2018 | 22 | |
| 19 | 2018 | 22 |
About Kun-Zhe Wu
Kun-Zhe Wu is a scholar working on Cancer Research, Oncology and Immunology and Allergy, having authored 19 papers that have together received 319 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (5 papers), RNA modifications and cancer (5 papers), Cancer-related molecular mechanisms research (5 papers), Gastric Cancer Management and Outcomes (3 papers), RNA Interference and Gene Delivery (2 papers), Colorectal Cancer Surgical Treatments (2 papers), Ferroptosis and cancer prognosis (2 papers) and Nanoparticle-Based Drug Delivery (2 papers). The work is most often cited by research in Cancer Research (118 citations), Biomaterials (40 citations) and Oncology (70 citations). Kun-Zhe Wu has collaborated with scholars based in China and Japan. Frequent co-authors include Cheng Zhang, Dong‐Qiu Dai, Chun‐Dong Zhang, Ming-Hui Ma, Jun‐Peng Pei, Jinlan Jiang, Liang Yu, Beibei Yu, Yu Liang and Yangyang Tian. Their work appears in journals such as Life Sciences, BioMed Research International and Genomics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.